We are live on ! Find out more
Vanguard Global Advisers

Vanguard Global Advisers Portfolio holdings

AUM $215B
This Fund
S&P 500
This Quarter Est. Return
+22.32%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215B
AUM Growth
+$28.1B
Cap. Flow
+$1.96B
Cap. Flow %
0.91%
Top 10 Hldgs %
41.33%
Holding
3,754
New
71
Increased
744
Reduced
1,650
Closed
116
Avg Time Held
1 quarter
Top 10 Avg Time Held
1 quarter
Top 20 Avg Time Held
0.9 quarters

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$189M
2
HON icon
Honeywell
HON
+$157M
3
AAPL icon
Apple
AAPL
+$124M
4
MSFT icon
Microsoft
MSFT
+$89M
5
AMZN icon
Amazon
AMZN
+$62.1M

Sector Composition

Rank Sector Weight
1 Technology 25.83%
2 Miscellaneous 25.2%
3 Financials 11.43%
4 Communication Services 6.64%
5 Consumer Discretionary 6.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KODK icon
1901
Kodak
KODK
$964M
$762K ﹤0.01%
82,431
+55,524
+206% +$609K
2026 Q1
1 quarter
STC icon
1902
Stewart Information Services
STC
$1.55B
$760K ﹤0.01%
11,517
-1,562
-12% -$104K
2026 Q1
1 quarter
IOSP icon
1903
Innospec
IOSP
$2.34B
$759K ﹤0.01%
9,331
-462
-5% -$36.6K
2026 Q1
1 quarter
GPRE icon
1904
Green Plains
GPRE
$1.05B
$759K ﹤0.01%
49,363
+7,557
+18% +$120K
2026 Q1
1 quarter
NUVB icon
1905
Nuvation Bio
NUVB
$1.95B
$759K ﹤0.01%
133,622
+10,460
+8% +$51.1K
2026 Q1
1 quarter
UMC icon
1906
United Microelectronic
UMC
$63.2B
$759K ﹤0.01%
27,891
-35,417
-56% -$605K
2026 Q1
1 quarter
RXRX icon
1907
Recursion Pharmaceuticals
RXRX
$2.18B
$759K ﹤0.01%
206,759
-40
-0% -$133
2026 Q1
1 quarter
JBIO
1908
Jade Biosciences
JBIO
$876M
$758K ﹤0.01%
34,093
+10,395
+44% +$217K
2026 Q1
1 quarter
SHOE
1909
Shoe Station Group
SHOE
$345M
$757K ﹤0.01%
51,078
+21,793
+74% +$372K
2026 Q1
1 quarter
FLYW icon
1910
Flywire
FLYW
$2.14B
$756K ﹤0.01%
43,027
-51
-0.1% -$753
2026 Q1
1 quarter
PAYO icon
1911
Payoneer
PAYO
$2.42B
$752K ﹤0.01%
105,687
-7,928
-7% -$43.4K
2026 Q1
1 quarter
MPB icon
1912
Mid Penn Bancorp
MPB
$910M
$751K ﹤0.01%
21,568
– –
2026 Q1
1 quarter
SNDX icon
1913
Syndax Pharmaceuticals
SNDX
$1.63B
$751K ﹤0.01%
34,371
-3,044
-8% -$63.3K
2026 Q1
1 quarter
PRDO icon
1914
Perdoceo Education
PRDO
$1.99B
$751K ﹤0.01%
23,476
-1,428
-6% -$49K
2026 Q1
1 quarter
CCNE icon
1915
CNB Financial Corp
CCNE
$998M
$751K ﹤0.01%
22,281
– –
2026 Q1
1 quarter
DEI icon
1916
Douglas Emmett
DEI
$1.63B
$751K ﹤0.01%
63,621
-3,064
-5% -$34.5K
2026 Q1
1 quarter
MLYS icon
1917
Mineralys Therapeutics
MLYS
$2.1B
$750K ﹤0.01%
27,783
-2,691
-9% -$73.8K
2026 Q1
1 quarter
PKE icon
1918
Park Aerospace
PKE
$646M
$749K ﹤0.01%
19,619
+12,162
+163% +$405K
2026 Q1
1 quarter
VRDN icon
1919
Viridian Therapeutics
VRDN
$2.15B
$749K ﹤0.01%
40,750
+5,425
+15% +$87.4K
2026 Q1
1 quarter
NN icon
1920
NextNav
NN
$2.32B
$748K ﹤0.01%
41,943
+7,199
+21% +$139K
2026 Q1
1 quarter
BXDC
1921
Blackstone Digital Infrastructure Trust
BXDC
$1.74B
$747K ﹤0.01%
+34,539
New +$750K
2026 Q2
0 quarters
EPAC icon
1922
Enerpac Tool Group
EPAC
$1.79B
$747K ﹤0.01%
20,820
– –
2026 Q1
1 quarter
OSBC icon
1923
Old Second Bancorp
OSBC
$1.25B
$744K ﹤0.01%
31,893
– –
2026 Q1
1 quarter
BY icon
1924
Byline Bancorp
BY
$1.68B
$742K ﹤0.01%
19,715
– –
2026 Q1
1 quarter
NEO icon
1925
NeoGenomics
NEO
$2.28B
$741K ﹤0.01%
50,793
– –
2026 Q1
1 quarter

Similar funds

Vanguard Global Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Vanguard Global Advisers held 3,754 positions worth $215B, up 15% from $187B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 5%. Vanguard Global Advisers opened 71 new positions and exited 116, leaving the 3,754-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Miscellaneous and Financials.

  • Vanguard Global Advisers's largest Q2 2026 buy was Honeywell Aerospace: 682,434 shares worth $151M.
  • Vanguard Global Advisers added most to Vanguard S&P 500 ETF in Q2 2026, an estimated $1.11B increase.
  • Vanguard Global Advisers's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $189M.
  • Vanguard Global Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $58.2M.
  • Vanguard Global Advisers's ten largest holdings make up 41% of its $215B portfolio in Q2 2026.
  • Vanguard Global Advisers opened 71 new positions and closed 116 in Q2 2026.
  • Vanguard Global Advisers's portfolio value rose 15% quarter-over-quarter to $215B.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.